Welcome to the 6th Microbiome Movement - Drug Development Summit Europe
As the first microbiome-based therapeutic steps closer to market approval, the scientific community continue to demonstrate the functional role of the human microbiome as a novel source of therapeutic, biomarker and diagnostic development. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.
The 6th Microbiome Movement – Drug Development Summit Europe will return online to unite leading scientists and industry partners surrounding the microbiome to pursue the causal role of the microbiome in disease, with the aim to obtain the first EMA-approved microbiome-targeted therapeutic from predictable modes of action and consistent clinical outcomes. Join us to explore the progress made in the last 12 months, and uncover where this microbiome space is heading!
50+ Expert Speakers Included
Hear What Our Customers Say
"As a newcomer to the microbiome field, this conference provided an excellent overview.”
“It was a great conference to effectively learn the current trends in microbiome drug development around the world.”